Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 4/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 7/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | RRM1 | P23921 | 1/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4249489 | 0.89 | GNAI3 (0.57) | EPHX1PAOXGNAI3GNAO1GNAI1 | |
| SCHEMBL42439 | 0.89 | — | — | |
| SCHEMBL25252984 | 0.88 | GNAI3 (0.60) | EPHX1PAOXGNAI3GNAO1GNAI1 | |
| SCHEMBL1479336 | 0.88 | GNAI3 (0.60) | EPHX1PAOXGNAI3GNAO1GNAI1 | |
| SCHEMBL11286835 | 0.88 | GNAI3 (0.60) | EPHX1PAOXGNAI3GNAO1GNAI1 | |
| Octadecylamine SCHEMBL910406 | 0.88 | GNAI3 (0.60) | EPHX1PAOXGNAI3GNAO1GNAI1 | |
| Hydrogen Sulfide SCHEMBL27527355 | 0.86 | — | — | |
| Hexane SCHEMBL28335720 | 0.86 | EPHX1 (0.62) | EPHX1ALOX15ACHEMMP2 | |
| Hydrochloric Acid SCHEMBL2398903 | 0.86 | — | — | |
| Iodide SCHEMBL23242193 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10799443-B2 | Crosslinkable coating compositions formulated with dormant carbamate initiator | ELEMENTIS SPECIALTIES, INC. (US) | 2020-10-13 | — | — | US | claimed |
| US-20200214966-A1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | ELEMENTIS SPECIALTIES, INC. (US) | 2020-07-09 | — | — | US | claimed |
| EP-3284792-B1 | METHOD FOR PREPARING CERAMIC INK COMPRISING METAL PRECURSOR AND CERAMIC PIGMENT AND CERAMIC INK MANUFACTURED BY THE SAME | INKTEC CO LTD (KR) | 2019-10-09 | — | — | EP | claimed |
| EP-2066497-B1 | MANUFACTURING METHODS FOR METAL CLAD LAMINATES | INKTEC CO LTD (KR) | 2018-11-07 | — | — | EP | claimed |
| EP-2013298-B1 | COMPOSITIONS FOR FORMING REFLECTING LAYER HAVING ORGANIC SILVER COMPLEXES,AND METHOD FOR PREPARING REFLECTING LAYER USING SAME | INKTEC CO LTD (KR) | 2018-06-27 | — | — | EP | claimed |
| US-20180118967-A1 | Metal Nanoparticle Ink Compositions For Printed Electronic Device Applications | XEROX CORPORATION | 2018-05-03 | — | — | US | claimed |
| EP-3284792-A1 | METHOD FOR PREPARING CERAMIC INK COMPRISING METAL PRECURSOR AND CERAMIC PIGMENT AND CERAMIC INK MANUFACTURED BY THE SAME | Inktec Co., Ltd. (KR) | 2018-02-21 | — | — | EP | claimed |
| US-9786843-B2 | Methods for fabricating an optoelectronic device | INKTEC CO., LTD. (KR) | 2017-10-10 | — | — | US | claimed |
| EP-2003976-B1 | USE OF AN ANTIBACTERIAL COMPOSITION CONTAINING ORGANIC SILVER COMPLEXES | INKTEC CO LTD (KR) | 2016-12-21 | — | — | EP | claimed |
| EP-2052043-B1 | PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME | INKTEC CO LTD (KR) | 2016-10-12 | — | — | EP | claimed |
| US-20080206488-A1 | Conductive Inks and Manufacturing Method Thereof | INKTEC CO., LTD. (KR) | 2008-08-28 | — | — | US | claimed |
| WO-2008103013-A1 | CONDUCTIVE FIBERS AND A METHOD OF MANUFACTURING THE SAME | INKTEC CO., LTD. (KR) | 2008-08-28 | — | — | WO | claimed |
| JP-2008531810-A | — | — | 2008-08-14 | — | — | JP | claimed |
| WO-2008018718-A1 | PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME | INKTEC CO., LTD. (KR) | 2008-02-14 | — | — | WO | claimed |
| EP-1853671-A1 | CONDUCTIVE INKS AND MANUFACTURING METHOD THEREOF | Inktec Co., Ltd. (KR) | 2007-11-14 | — | — | EP | claimed |
| WO-2007126277-A1 | ALUMINUM WHEEL HAVING HIGH GLOSS | INKTEC CO., LTD. (KR) | 2007-11-08 | — | — | WO | claimed |
| EP-1846422-A1 | ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS | Inktec Co., Ltd. (KR) | 2007-10-24 | — | — | EP | claimed |
| WO-2007105912-A1 | ANTIBACTERIAL COMPOSITION CONTAINING ORGANIC SILVER COMPLEXES, ANTIBACTERIAL TREATMENT METHODS USING THE SAME AND ANTIBACTERIAL FORMED ARTICLE | INKTEC CO., LTD. (KR) | 2007-09-20 | — | — | WO | claimed |
| WO-2006093398-A1 | CONDUCTIVE INKS AND MANUFACTURING METHOD THEREOF | INKTEC CO., LTD. (KR) | 2006-09-08 | — | — | WO | claimed |
| WO-2006083153-A1 | ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS | INKTEC CO., LTD. (KR) | 2006-08-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200214966-A1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | ETF1, CECR2, H1-2 | EPHX1 2384/4885ALOX15 3158/4885PAOX 3989/4885 |
| US-10799443-B2 | Crosslinkable coating compositions formulated with dormant carbamate initiator | ETF1, CECR2, H1-2 | EPHX1 2384/4885ALOX15 3158/4885PAOX 3989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.